{
  "authors": [
    {
      "author": "Clodagh S O'Gorman"
    },
    {
      "author": "Rayzel Shulman"
    },
    {
      "author": "Irene Lara-Corrales"
    },
    {
      "author": "Elena Pope"
    },
    {
      "author": "Margaret Marcon"
    },
    {
      "author": "Hartmut Grasemann"
    },
    {
      "author": "Rayfel Schneider"
    },
    {
      "author": "Julia Upton"
    },
    {
      "author": "Etienne B Sochett"
    },
    {
      "author": "Dror Koltin"
    },
    {
      "author": "Eyal Cohen"
    }
  ],
  "doi": "10.1186/1752-1947-7-44",
  "publication_date": "2013-02-16",
  "id": "EN116626",
  "url": "https://pubmed.ncbi.nlm.nih.gov/23409957",
  "source": "Journal of medical case reports",
  "source_url": "",
  "licence": "CC BY",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "We discuss a profoundly affected 2.9-year-old Caucasian girl of Western European descent with a dramatic response to immunosuppression (initially azathioprine and oral steroids, and then subsequently mycophenolate mofetil monotherapy). At four years of follow-up, her response to mycophenolate mofetil is excellent."
}